HORIZON-HLTH-DISEASE-2022-06-two-stage-02: Pre-clinical development of the next generation immunotherapies for diseases or disorders with unmet medical need

Year: 2022
Type of action: RIA
Expected EU contribution per project: 6M€
Deadline: first stage 01/02/2022 second stage 06/09/2022